Role of ADAMTSL4 Mutations in FBN1 Mutation-Negative Ectopia Lentis Patients.

Jose Antonio Aragon-Martin (1) , Dana Ahnood (1) , David G Charteris (2) , Anand Saggar (3) , Ken K Nischal (4) , Paolo Comeglio (1) , Aman Chandra (2) , Anne Child (1) , Gavin Arno (1)

1 Cardiac & Vascular Sciences
2 VRE - Vitreo-retinal Unit
3 Clinical Genetics Unit
4 Department of Ophthalmology

Ectopia lentis (EL) is genetically heterogeneous with both autosomal-dominant and -recessive forms. The dominant disorder can be caused by mutations in FBN1, at the milder end of the type-1 fibrillinopathies spectrum. Recently in a consanguineous Jordanian family, recessive EL was mapped to locus 1q21 containing the ADAMTSL4 gene and a nonsense mutation was found in exon 11 (c.1785T>G, p.Y595X). In this study, 36 consecutive probands with EL who did not fulfill the Ghent criteria for MFS were screened for mutations in FBN1 and ADAMTSL4. Causative FBN1 mutations were identified in 23/36 (64%) of probands while homozygous or compound heterozygous ADAMTSL4 mutations were identified in 6/12 (50%) of the remaining probands. Where available, familial screening of these families confirmed the mutation co-segregated with the EL phenotype. This study confirms that homozygous frameshift mutations in ADAMTSL4 are associated with autosomal-recessive EL in British families. Furthermore; the first compound heterozygous mutation is described resulting in a PTC and a missense mutation in the PLAC (protease and lacunin) domain. The identification of a causative mutation in ADAMTSL4 may allow the exclusion of Marfan syndrome in these families and guide the clinical management, of particular relevance in young children affected by EL.

Mots clés: Life Sciences

Jose Antonio Aragon-Martin, Dana Ahnood, David G Charteris, Anand Saggar, Ken K Nischal, et al.. Role of ADAMTSL4 Mutations in FBN1 Mutation-Negative Ectopia Lentis Patients.. Human Mutation, 2010, 31 (8), ⟨10.1002/humu.21305⟩. ⟨hal-00552405⟩